Skip to main content
. 2016 Jan 19;15:7. doi: 10.1186/s12937-016-0125-5

Table 3.

Mean plasma and feces concentrations and renal excretion of minerals during the study periods

Parameter P1000/Ca0 P1000/Ca500 P1000/Ca1000
Plasma calcium [mmol/l]
 Placebo 2.36±0.08 2.36ab±0.06 2.36±0.08
 4 weeks 2.34±0.07 2.35a±0.05 2.38±0.08
 8 weeks 2.37±0.09 2.39b±0.07 2.39±0.09
Fecal calcium [mg/g feces]
 Placebo 9±5 7±3* 8±3*
 8 weeks 8±4 11±5 12±6
Plasma phosphate [mmol/l]
 Placebo 1.20±0.23 1.28±0.16 1.19±0.23
 4 weeks 1.19±0.19 1.24±0.14 1.23±0.20
 8 weeks 1.18±0.23 1.20±0.12 1.23±0.19
Fecal phosphorus [mg/g feces]
 Placebo 5±2* 5±2* 6±3*
 8 weeks 8±4 8±4 8±3
Plasma magnesium [mmol/l]
 Placebo 0.82±0.06 0.83±0.04 0.82±0.05
 4 weeks 0.82±0.05 0.83±0.04 0.82±0.05
 8 weeks 0.83±0.05 0.84±0.05 0.81±0.05
Urine magnesium [mg/d]
 Placebo 113a±41 110±30 106±48
 4 weeks 89b±39 103±36 91±42
 8 weeks 84b±32 103±53 106±56
Fecal magnesium [mg/g feces]
 Placebo 2±1 2±1 2±1
 8 weeks 2±1 2±1 2±1

n = 62 for plasma and minerals in urine; n = 61 for fecal minerals; data are expressed as mean ± standard deviation; P1000/Ca0: 1000 mg phosphorus/0 mg calcium; P1000/Ca500: 1000 mg phosphorus/500 mg calcium; P1000/Ca1000: 1000 mg phosphorus/1000 mg calcium; a b mean values within a column with dissimilar superscript lower case letters are significantly different (p ≤ 0.05); * significant different to eight weeks within each group (p ≤ 0.05); effect of time was tested using general linear model with repeated measurements (with pairwise comparisons based on Bonferroni); fecal minerals were tested with paired and with unpaired Students t-Test within each intervention group and between intervention groups, respectively.